According to Antu Biotech's announcement, the company and its wholly-owned subsidiary Antu Instruments and the second-level subsidiary Zhengzhou Biaoyuan recently received a total of 8 medical device registration certificates issued by the State Drug Administration and the Henan Drug Administration, covering products such as HIV-1 nucleic acid detection kits, eBV nuclear antigen IgG antibody test kits, fully automatic coagulation analyzers, and various respiratory antibody quality control products II. The registration certificates are valid for 5 years. Obtaining the above registration certificate can enrich the company's product menu, is an effective complement to existing testing products, and has little impact on the company's operating performance in the short term.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.